T cells in organ ischemia reperfusion injury

Current Opinion in Organ Transplantation

Volumn 19, Issue 2, 2014, Pages 115-120

  Rao, Jianhua ^a,b   Lu, Ling ^a,b   Zhai, Yuan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

IL 17; innate immune activation; ischemia reperfusion injury; regulatory T cell; T cells; Th1; Th17

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE;

ADAPTIVE IMMUNITY; ANTIGEN SPECIFICITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE RELEASE; HOMEOSTASIS; HUMAN; IMMUNOREGULATION; IMMUNOSTIMULATION; INFLAMMATION; INNATE IMMUNITY; MEMORY T LYMPHOCYTE; NONHUMAN; PATHOGENESIS; REGULATORY T LYMPHOCYTE; REPERFUSION INJURY; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TISSUE REPAIR;

HUMANS; LYMPHOCYTE ACTIVATION; ORGAN TRANSPLANTATION; REPERFUSION INJURY; T-LYMPHOCYTE SUBSETS;

EID: 84897109456     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0000000000000064     Document Type: Review

References (49)

1. Stabile E, Burnett MS, Watkins C, et al. Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice. Circulation 2003; 108:205-210.
2. Brait VH, Arumugam TV, Drummond GR, Sobey CG. Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia. J Cereb Blood Flow Metab 2012; 32:598-611.
3. Rabb H, Daniels F, O'Donnell M, et al. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 2000; 279:F525-531.
4. Caldwell CC, Tschoep J, Lentsch AB. Lymphocyte function during hepatic ischemia/reperfusion injury. J Leukoc Biol 2007; 82:457-464.
5. Yilmaz G, Arumugam TV, Stokes KY, Granger DN. Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 2006; 113:2105-2112.
6. Burne MJ, Daniels F, El Ghandour A, et al. Identification of the CD4+ T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 2001; 108:1283-1290.
7. Kleinschnitz C, Schwab N, Kraft P, et al. Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood 2010; 115:3835-3842.
8. Shichita T, Sugiyama Y, Ooboshi H, et al. Pivotal role of cerebral interleukin- 17-producing gammadelta T cells in the delayed phase of ischemic brain injury. Nat Med 2009; 15:946-950.
9. Takada M, Chandraker A, Nadeau KC, et al. The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest 1997; 100:1199-1203.
10. Hochegger K, Schätz T, Eller P, et al. Role of alpha/beta and gamma/delta T cells in renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 2007; 293:F741-F747.
11. Kuboki S, Sakai N, Tschop J, et al. Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2009; 296:G1054-G1059.
12. Satpute SR, Park JM, Jang HR, et al. The role for T cell repertoire/antigenspecific interactions in experimental kidney ischemia reperfusion injury. J Immunol 2009; 183:984-992.
13. Shen X, Wang Y, Gao F, et al. CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury. Hepatology 2009; 50:1537-1546.
14. Shen X, Reng F, Gao F, et al. Alloimmune activation enhances innate tissue inflammation/injury in a mouse model of liver ischemia/reperfusion injury. Am J Transplant 2010; 10:1729-1737.
15. Day YJ, Huang L, Ye H, et al. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFNgamma. J Immunol 2006; 176:3108-3114.
16. Li L, Huang L, Sung SS, et al. NKT cell activation mediates neutrophil IFN- {gamma} production and renal ischemia-reperfusion injury. J Immunol 2007; 178:5899-5911.
17. Li L, Huang L, Vergis AL, et al. IL-17 produced by neutrophils regulates IFNgamma- mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest 2010; 120:331-342.
18. Zhai Y, Qiao B, Gao F, et al. Type I, but not type II, interferon is critical in liver injury induced after ischemia and reperfusion. Hepatology 2008; 47:199-206.
19. Shen XD, Ke B, Ji H, et al. Disruption of Type-I IFN pathway ameliorates preservation damage in mouse orthotopic liver transplantation via HO-1 dependent mechanism. Am J Transplant 2012; 12:1730-1739.
20. Shen XD, Ke B, Zhai Y, et al. CD154-CD40 T-cell costimulation pathway is required in the mechanism of hepatic ischemia/reperfusion injury, and its blockade facilitates and depends on heme oxygenase-1 mediated cytoprotection. Transplantation 2002; 74:315-319.
21. Andrade RM, Wessendarp M, Subauste CS. CD154 activates macrophage antimicrobial activity in the absence of IFN-gamma through a TNF-alphadependent mechanism. J Immunol 2003; 171:6750-6756.
22. Abdi K, Singh NJ. Antigen-activated T cells induce IL-12p75 production from dendritic cells in an IFN-gamma-independent manner. Scand J Immunol 2010; 72:511-521.
23. Ji H, Shen X, Gao F, et al. Programmed death-1/B7-H1 negative costimulation protects mouse liver against ischemia and reperfusion injury. Hepatology 2010; 52:1380-1389.
24. Uchida Y, Ke B, Freitas MC, et al. The emerging role of T cell immunoglobulin mucin-1 in the mechanism of liver ischemia and reperfusion injury in the mouse. Hepatology 2010; 51:1363-1372.
25. Uchida Y, Ke B, Freitas MC, et al. T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner. Gastroenterology 2010; 139:2195-2206.
26. Zhang Y, Ji H, Shen X, et al. Targeting TIM-1 on CD4 T cells depresses macrophage activation and overcomes ischemia-reperfusion injury in mouse orthotopic liver transplantation. Am J Transplant 2013; 13:56-66.
27. Kato A, Graul-Layman A, Edwards MJ, Lentsch AB. Promotion of hepatic ischemia/reperfusion injury by IL-12 is independent of STAT4. Transplantation 2002; 73:1142-1145.
28. Shen XD, Ke B, Zhai Y, et al. Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection. Hepatology 2003; 37:296-303.
29. Yokota N, Burne-Taney M, Racusen L, Rabb H. Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 2003; 285:F319-F325.
30. Kono H, Fujii H, Ogiku M, et al. Role of IL-17A in neutrophil recruitment and hepatic injury after warm ischemia-reperfusion mice. J Immunol 2011; 187:4818-4825.
31. Feng M, Li G, Qian X, et al. IL-17A-producing NK cells were implicated in liver injury induced by ischemia and reperfusion. Int Immunopharmacol 2012; 13:135-140.
32. Tan Z, Jiang R, Wang X, et al. RORgammat+IL-17+ neutrophils play a critical role in hepatic ischemia-reperfusion injury. J Mol Cell Biol 2013; 5:143-146.
33. Loi P, Yuan Q, Torres D, et al. IRF3 deficiency leads to IL-17-mediated liver ischemia-reperfusion injury. Hepatology 2012; 57:371-376.
34. Eggenhofer E, Rovira J, Sabet-Baktach M, et al. Unconventional RORgt+ T cells drive hepatic ischemia reperfusion injury. J Immunol 2013; 191:480-487.
35. Park SW, Kim M, Brown KM, et al. Paneth cell-derived interleukin-17A causes multiorgan dysfunction after hepatic ischemia and reperfusion injury. Hepatology 2011; 53:1662-1675.
36. Gelderblom M, Weymar A, Bernreuther C, et al. Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke. Blood 2012; 120:3793-3802.
37. Ranganathan PV, Jayakumar C, Mohamed R, et al. Netrin-1 regulates the inflammatory response of neutrophils and macrophages, and suppresses ischemic acute kidney injury by inhibiting COX-2-mediated PGE2 production. Kidney Int 2013; 83:1087-1098.
38. Liao YH, Xia N, Zhou SF, et al. Interleukin-17A contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration. J Am Coll Cardiol 2012; 59:420-429.
39. Sharma AK, LaPar DJ, Zhao Y, et al. Natural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury. Am J Respir Crit Care Med 2011; 183:1539-1549.
40. Sharma AK, LaPar DJ, Stone ML, et al. Receptor for advanced glycation end products (RAGE) on iNKT cells mediates lung ischemia-reperfusion injury. Am J Transplant 2013; 13:2255-2267.
41. Hata T, Takahashi M, Hida S, et al. Critical role of Th17 cells in inflammation and neovascularization after ischaemia. Cardiovasc Res 2011; 90:364-372.
42. Gandolfo MT, Jang HR, Bagnasco SM, et al. Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int 2009; 76:717-729.
43. Kinsey GR, Sharma R, Huang L, et al. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol 2009; 20:1744-1753.
44. Liesz A, Suri-Payer E, Veltkamp C, et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 2009; 15:192-199.
45. Kleinschnitz C, Kraft P, Dreykluft A, et al. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood 2013; 121:679-691.
46. Zouggari Y, Ait-Oufella H, Waeckel L, et al. Regulatory T cells modulate postischemic neovascularization. Circulation 2009; 120:1415-1425.
47. Kinsey GR, Huang L, Jaworska K, et al. Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection. J Am Soc Nephrol 2012; 23:1528-1537.
48. Kim MG, Jung Cho E, Won Lee J, et al. The heat-shock protein-70-induced renoprotective effect is partially mediated by CD4CD25Foxp3 regulatory T cells in ischemia/reperfusion-induced acute kidney injury. Kidney Int 2013; 24:277.
49. Feng M, Wang Q, Zhang F, Lu L. Ex vivo induced regulatory T cells regulate inflammatory response of Kupffer cells by TGF-beta and attenuate liver ischemia reperfusion injury. Int Immunopharmacol 2012; 12:189-196.